Trusted Resources: Education
Scientific literature and patient education texts
Mucopolysaccharidosis Patients Have Reduced Functional Capacity
source: Pediatric pulmonology
year: 2022
authors: Dias BMC,Lanza FC,Santos JD,Aranda CS,Solé D,Martins AM,Wandalsen GF
summary/abstract:Mucopolysaccharidoses (MPSs) are a group of rare diseases caused by an intralysosomal accumulation of glycosaminoglycans, resulting in a multisystemic clinical condition characterized by variable degrees of physical-functional impairment.
organization: Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, São Paulo, Brazil.DOI: 10.1002/ppul.25750
read more
BookmarkRelated Content
-
Mucopolysaccharidosis II (MPS II) in a Free-Living Kaka (Nestor Meridionalis) in New ZealandA lysosomal storage disease, identified ...
-
Carpal Tunnel Syndrome and Finger Deformities in Children With Mucopolysaccharidoses and Mucolipidoses: A Retrospect...This single-centre retrospective study r...
-
Secondary Ganglioside GM2 Accumulation in MucopolysaccharidosesIn vivo, the lysosomal degradation of GM...
-
A Rare Specialism: A Look at the Last Ten Years in MPS Management, Presented by Dr Christina Lampehttps://www.youtube.com/watch?v=EjNEVoWT...
-
Mucopolysaccharidoses Fact SheetThe mucopolysaccharidoses are a group of...
-
Johns Hopkins – Lysosomal Storage Disease CenterLysosomes are packets of enzymes or othe...
-
Family Assistance ProgramProgram provides grants of up to $3000 f...
Powered by
